MAR vs SBUX: Which Is the Better Buy?

Side-by-side comparison of Marriott International, Inc. and Starbucks Corporation β€” fair value, conviction, valuation metrics, and QuantHub research signals. Updated 2026-09-18.
Marriott International, Inc. Β· Consumer Cyclical
$334.97
+20.6% upside to fair value
Med Conviction Grade C
VS
Starbucks Corporation Β· Consumer Cyclical
$96.67
+12.3% upside to fair value
Med Conviction Grade C
QuantHub Verdict
MAR has more upside to fair value (+20.6%). These are model outputs β€” not personalized investment advice. See all research β†’
Valuation & Fundamentals
Metric MAR SBUX
Current Price $334.97 $96.67
Fair Value Estimate $403.81 $108.52
Upside to Fair Value +20.6% +12.3%
Market Cap $87.3B $110.2B
Forward P/E β€” β€”
EV / EBITDA 22.2x 22.0x
Price / Sales 3.2x 2.9x
Price / FCF 28.7x 30.4x
Revenue Growth YoY +4.8% -1.4%
Gross Margin 20.2% 31.7%
Operating Margin 15.8% 9.4%
Return on Equity -66.7% -24.3%
Dividend Yield 0.84% 2.57%
FCF Yield 3.48% 3.29%
Analyst Consensus Hold Buy
Investment Thesis
MAR β€” Marriott International, Inc.
Marriott International is a global asset-light hotel franchisor and manager whose 10,082-property, 1.814 million-room system, 629,000-room development pipeline, broad brands, and more than 295 million Bonvoy members support durable fee-led economics. Business quality is tempered by cyclicality, competitive owner incentives, and $16.915 billion of debt, while reported ROE is negative 66.7%. In the…
SBUX β€” Starbucks Corporation
Starbucks is the world's largest specialty coffee retailer, operating company-owned and licensed coffeehouses across North America, International, and Channel Development segments, with a brand that has historically supported premium pricing and global scale. The business quality is currently strained: revenue declined 1.4% year over year in the most recent quarter, TTM operating margin is 9.4%, …
Accumulation Zones
Metric MAR SBUX
Zone Low $302.86 $81.39
Zone High $343.24 $92.24
In Buy Zone? Yes No
← MAR Research    SBUX Research β†’    All Research